Silverback Asset Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-788,011
Closed -$442 56
2019
Q3
$442 Hold
788,011
0.07% 48
2019
Q2
$410K Hold
788,011
0.06% 49
2019
Q1
$355K Hold
788,011
0.06% 42
2018
Q4
$378K Hold
788,011
0.07% 52
2018
Q3
$418K Hold
788,011
0.07% 49
2018
Q2
$394K Buy
788,011
+338,011
+75% +$157K 0.05% 47
2018
Q1
$190K Hold
450,000
0.04% 47
2017
Q4
$171K Hold
450,000
0.03% 49
2017
Q3
$162K Hold
450,000
0.03% 50
2017
Q2
$171K Buy
+450,000
New +$184K 0.06% 27
2016
Q1
Sell
-861,200
Closed -$97K 78
2015
Q4
$97K Sell
861,200
-63,100
-7% -$8.91K 0.02% 41
2015
Q3
$176 Sell
924,300
-102,100
-10% -$34.7K 0.02% 40
2015
Q2
$718 Hold
1,026,400
0.1% 40
2015
Q1
$696 Hold
1,026,400
0.14% 40
2014
Q4
$811K Buy
1,026,400
+101,800
+11% +$69.5K 0.1% 45
2014
Q3
$430K Hold
924,600
0.05% 45
2014
Q2
$462 Sell
924,600
-657,810
-42% -$318K 0.05% 55
2014
Q1
$491 Sell
1,582,410
-581,099
-27% -$216K 0.03% 58
2013
Q4
$736 Buy
2,163,509
+655,271
+43% +$792K 0.06% 56
2013
Q3
$3.05M Buy
1,508,238
+508,238
+51% +$968K 0.26% 52
2013
Q2
$1.9K Buy
+1,000,000
New +$1.76M 0.17% 51

Other funds holding GCVRZ

Silverback Asset Management's GCVRZ Position: Q4 2019 in Review

Silverback Asset Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2019, closing a stake of 788,011 shares — an estimated $442 sold.

Silverback Asset Management first reported a position in GCVRZ in Q2 2013 and held it in 21 quarters. The position peaked at $3.05M in Q3 2013. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2019.

  • Silverback Asset Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
  • Silverback Asset Management sold 788,011 Sanofi Contingent Value Rights shares in Q4 2019, an estimated $442.
  • Silverback Asset Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 21 quarters.
  • Silverback Asset Management's Sanofi Contingent Value Rights position peaked at $3.05M in Q3 2013.
  • 103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2019.

Based on Silverback Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.